DRACP04901 |
Fusaripeptide A |
IYQAATX |
7 |
|
DRACP04902 |
|
IYSFDGRDIMTDPSWPQKVIWHGSSPHGVRLVDNYCEAWRTA |
42 |
Synthetic |
DRACP04903 |
|
KAFDITYVRLKF |
12 |
Synthetic |
DRACP04904 |
scFSEN |
KCGHKHQCAVHN |
12 |
Synthetic |
DRACP04905 |
|
KGRGKRRRCKQRPSDCPRR |
19 |
Synthetic |
DRACP04906 |
|
KGRGKRRRECQRPSCKPRR |
19 |
Synthetic |
DRACP04907 |
|
KIKSCYYLPCFVTS |
14 |
Synthetic |
DRACP04908 |
aa 129-138; partial loop-4+loop-5 |
KITRCPMIPC |
10 |
Synthetic |
DRACP04909 |
aa 129-145; partial loop-4+loop-5 |
KITRCPMIPCYISSPDE |
17 |
Synthetic |
DRACP04910 |
|
KNECLWTDMLSNFGYPGYQSKHYACIRQKG |
30 |
Synthetic |
DRACP04911 |
|
KRFKQDGGWSHWSPWSSC |
18 |
Synthetic |
DRACP04912 |
|
KRRREKQRPCDKPRR |
15 |
Synthetic |
DRACP04913 |
|
KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISAST |
39 |
Synthetic |
DRACP04914 |
|
KSCCPNTTGRNIYNACRLTGAPRPTCAKLSGCKIISGST |
39 |
Synthetic |
DRACP04915 |
|
KSCCPNTTGRNIYNTCRFAGGSRERCAKLSGCKIISAST |
39 |
Synthetic |
DRACP04916 |
|
KSCCPNTTGRNIYNTCRFGGGSREVCARISGCKIISAST |
39 |
Synthetic |
DRACP04917 |
|
KSCCPNTTGRNIYNTCRFGGGSRQVCASLSGCKIISAST |
39 |
Synthetic |
DRACP04918 |
|
KSCCPNTTGRNIYNTCRLGGGSRERCASLSGCKIISAST |
39 |
Synthetic |
DRACP04919 |
|
KSCCPNTTGRNIYNTCRLTGSSRETCAKLSGCKIISAST |
39 |
Synthetic |
DRACP04920 |
|
KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGT |
39 |
Synthetic |
DRACP04921 |
VEGFderived peptide |
KSVRGKGKGQKRKRKKSRYK |
20 |
Exon 6a of VEGF gene |
DRACP04922 |
|
LGTNPLKSSGIE |
12 |
Synthetic |
DRACP04923 |
|
LHCPALVTYNTDTFESMPNPEGRYTFGASCV |
31 |
Synthetic |
DRACP04924 |
|
LLRISLLLIQSWLE |
14 |
Synthetic |
DRACP04925 |
|
LPGLTGSKGVRGISGLPGFSG |
21 |
Synthetic |
DRACP04926 |
Hexastatin-3 |
LPRFSTMPFIYCNINEVCHY |
20 |
Homo sapiens (α6 CIV) |
DRACP04927 |
Tetrastatin-1 |
LPVFSTLPFAYCNIHQVCH |
19 |
Homo sapiens (α4 CIV) |
DRACP04928 |
Pentastatin-1 |
LRRFSTMPFMFCNINNVCNF |
20 |
Homo sapiens (α5 CIV) |
DRACP04929 |
|
LRSRGELVAKFLAGEQSPEDYVAE |
24 |
Synthetic |
DRACP04930 |
|
LSSTCILVLVKDILVLVVKEILVLVVKDKPI |
31 |
Synthetic |